Documentary 'You Can See Everything' drives surge in Theranos-related media consumption

Nathan Fielder's documentary You Can See Everything has quickly become the highest-grossing U.S. documentary in the past 15 years, two weeks after its theatrical release. The film, co-directed by Lance Oppenheim, blends satire with investigative storytelling about former Theranos founder Elizabeth Holmes, whose fraud conviction resulted in a sentence of more than 11 years in prison.

The documentary’s popularity appears to be reviving interest in earlier coverage of the Theranos scandal. John Carreyrou's book Bad Blood has re-entered bestseller lists, the ABC News podcast The Dropout reported a 900 % rise in listeners, and the Disney/Hulu series The Dropout—originally released in 2022—has seen a 700 % increase in viewership, now ranking among the most-watched shows on IMDb.

You Can See Everything revisits key moments from Holmes’s testimony, including a deposition exchange in which she said, "I-I-I don’t know exactly what the number was … I think there were probably tens of tests …" The documentary juxtaposes these statements with the broader narrative of Theranos’s failed blood-testing technology and the resulting legal and ethical fallout.

The television adaptation, starring Amanda Seyfried as Holmes and Naveen Andrews as former boyfriend and business partner Sunny Balwani, dramatizes the rise and collapse of the company while adding artistic elements such as musical sequences. Critics note that the series, like the earlier podcast, is grounded in documented facts about the company’s technical shortcomings, internal surveillance, and the tragic suicide of former chief scientist Ian Gibbons.

Overall, the renewed attention underscores the lasting impact of the Theranos case on public discourse about corporate fraud and the media’s role in chronicling high-profile deceptions.